Article Text

Download PDFPDF
Paper
Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?
  1. Scott YH Kim1,
  2. Renee Wilson2,
  3. Raymond De Vries3,4,
  4. Kerry A Ryan4,
  5. Robert G Holloway5,
  6. Karl Kieburtz5,6
  1. 1Department of Bioethics, National Institutes of Health, Bethesda, Maryland, USA
  2. 2Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY, USA
  3. 3Department of Learning Health Sciences, University of Michigan, Ann Arbor, MI, USA
  4. 4Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, USA
  5. 5Department of Neurology, University of Rochester, Rochester, NY, USA
  6. 6Clinical and Translational Science Institute, University of Rochester, Rochester, NY, USA
  1. Correspondence to Dr Scott YH Kim, Department of Bioethics, National Institutes of Health, Clinical Center, 10 Center Drive, 1C118, Bethesda, MD 20892, USA, scott.kim{at}nih.gov, scottkim{at}med.umich.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles